Can-Fite BioPharma Ltd. (CANF) › Operating Cash FlowCan-Fite BioPharma Ltd. (CANF) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$8.97M2018: -$4.16M2019: -$11.08M2020: -$12.06M2021: -$9.86M2022: -$10.80M2023: -$8.44M2024: -$7.64M2025: -$8.95M-$8.95M2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$8.95M-17.2%2024-$7.64M+9.5%2023-$8.44M+21.9%2022-$10.80M-9.6%2021-$9.86M+18.3%2020-$12.06M-8.8%2019-$11.08M-166.8%2018-$4.16M+53.7%2017-$8.97M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share